HUTCHMED (China) Limited vs Ligand Pharmaceuticals Incorporated: Annual Revenue Growth Compared

Biopharma Revenue Growth: HUTCHMED vs. Ligand

__timestamp	HUTCHMED (China) Limited	Ligand Pharmaceuticals Incorporated
Wednesday, January 1, 2014	91813000	64538000
Thursday, January 1, 2015	178203000	71914000
Friday, January 1, 2016	216080000	108973000
Sunday, January 1, 2017	241203000	141102000
Monday, January 1, 2018	214109000	251453000
Tuesday, January 1, 2019	204890000	120282000
Wednesday, January 1, 2020	227976000	186419000
Friday, January 1, 2021	356128000	277133000
Saturday, January 1, 2022	426409000	196245000
Sunday, January 1, 2023	837999000	131314000

Igniting the spark of knowledge

A Tale of Two Companies: Revenue Growth in the Biopharmaceutical Sector

In the ever-evolving landscape of biopharmaceuticals, HUTCHMED (China) Limited and Ligand Pharmaceuticals Incorporated have showcased contrasting revenue trajectories over the past decade. From 2014 to 2023, HUTCHMED's revenue surged by over 800%, reflecting its strategic expansion and innovation in the Chinese market. In contrast, Ligand Pharmaceuticals experienced a more modest growth of approximately 100%, highlighting its steady yet less aggressive market approach.

Key Insights

HUTCHMED's Growth: Starting with a revenue of $91 million in 2014, HUTCHMED reached an impressive $838 million by 2023, marking a significant leap in its market presence.
Ligand's Stability: Ligand's revenue, while growing from $65 million in 2014 to $131 million in 2023, indicates a stable but less dynamic growth pattern.

This comparison underscores the diverse strategies and market dynamics within the biopharmaceutical industry.

Published by

U.S. Securities and Exchange Commission

Source link

sec.gov

Date published

17 Jan 2025

Similar Statistics

Novo Nordisk A/S vs Ligand Pharmaceuticals Incorporated: Examining Key Revenue Metrics

AbbVie Inc. and HUTCHMED (China) Limited: A Comprehensive Revenue Analysis

Comparing Revenue Performance: Merck & Co., Inc. or Ligand Pharmaceuticals Incorporated?

Comparing Revenue Performance: Takeda Pharmaceutical Company Limited or HUTCHMED (China) Limited?

BeiGene, Ltd. vs Ligand Pharmaceuticals Incorporated: Examining Key Revenue Metrics

Bio-Techne Corporation vs Ligand Pharmaceuticals Incorporated: Annual Revenue Growth Compared

Annual Revenue Comparison: Catalent, Inc. vs Ligand Pharmaceuticals Incorporated

Jazz Pharmaceuticals plc and HUTCHMED (China) Limited: A Comprehensive Revenue Analysis

Breaking Down Revenue Trends: Pharming Group N.V. vs Ligand Pharmaceuticals Incorporated

Lantheus Holdings, Inc. or HUTCHMED (China) Limited: Who Leads in Yearly Revenue?

Revenue Showdown: Bausch Health Companies Inc. vs Ligand Pharmaceuticals Incorporated

Who Generates More Revenue? Ligand Pharmaceuticals Incorporated or Mesoblast Limited